44. Lavnikova N, Laskin DL (1995) Unique patterns of regulation of nitric oxide production in fibroblasts. J Leukoc Biol 58: 451–458. 45. Auch CJ, Saha RN, Sheikh FG, Liu X, Jacobs BL, et al. (2004) Role of protein kinase R in double-stranded RNA-induced expression of nitric oxide synthase in human astroglia. FEBS Lett 563: 223–228. 46. Uetani K, Arroliga ME, Erzurum SC (2001) Double-stranded RNA dependence of nitric oxide synthase 2 expression in human bronchial epithelial cell lines BET-1A and BEAS-2B. Am J Respir Cell Mol Biol 24: 720–726. 47. Lundberg JO, Weitzberg E, Gladwin MT (2008) The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discovery 7: 156–167. 48. Fujii S, Akaike T, Maeda H (1999) Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virololgy 256: 203–212. 49. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, et al. (1993) Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261: 1445–1448. 50. Melkova Z, Esteban M (1995) Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J Immunol. pp 5711–5718. 51. Stamler JS, Lamas S, Fang FC (2001) Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106: 675–683. 52. Colasanti M, Persichini T, Venturini G, Ascenzi P (1999) S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. IUBMB Life 48: 25–31. 53. Saura M, Zaragoza C, McMillan A, Quick RA, Hohenadl C, et al. (1999) An antiviral mechanism of nitric oxide, inhibition of a viral protease. Immunity 10: 21–28. 54. Rimmelzwaan GF, Baars MM, deLijster P, Fouchier RA, Osterhaus AD (1999) Inhibition of influenza virus replication by nitric oxide. J Virol 73: 8880–8883. 55. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254: 1001–1003. 56. Lee CS, Won C, Yoo H, Yi EH, Cho Y, et al. (2009) Inhibition of double- stranded RNA-induced inducible nitric oxide synthase expression by fraxinel- lone and sauchinone in murine microglia. Biol Pharm Bull 32: 1870–1874. dsRNA-Mediated Nitric Oxide Response 57. Zaragoza C, Ocampo CJ, Saura M, Bao C, Leppo M, et al. (1999) Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. J Immunol 163: 5497–5504. 58. MacLean A, Wei XQ, Huang FP, Al-Alem UAH, Chan WL, et al. (1998) Mice lacking inducible nitric oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J Gen Virol 79: 825–830. 59. Chu SC, Marks-Konczalik J, Wu H, Banks TC, Moss J (1998) Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Comm 248: 871–878. 60. LePage C, Sanceau J, Drapier JC, Wietzerbin J (1996) Differential expression of inducible NO synthase in two murine macrophage cell lines. Immunology 89: 274–280. 61. Farlik M, Reutterer B, Schindler C, Greten F, Vogi C, et al. (2010) Nonconventional initiation complex assembly by STAT and NF-kB transcrip- tion factors regulates nitric oxide synthase expression. Immunity 33: 25–34. 62. Spitsin SV, Farber JL, Bertovich M, Moehren G, Koprowski H, et al. (1997) Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-KB. Mol Med 3: 315–326. 63. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, et al. (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612–1615. 64. Honda K, Taniguchi T (2006) IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immun 9: 644–658. 65. Blair LA, Maggi LB, Scarim AL, Corbett JA (2002) Role of interferon regulatory factor 1 in double-stranded RNA-induced iNOS expression by mouse islets. J Biol Chem 277: 359–365. 66. Minaker RL, Mossman KL, Smiley JR (2005) Functional inaccessibility of quiescent herpes simplex virus genomes. Virol J 2: 85. 67. Nazli A, Yao XD, Smieja M, Rosenthal KL, Ashkar AA, et al. (2009) Differential induction of innate anti-viral responses by TLR ligands against herpes simplex virus, type 2, infection in primary genital epithelium of women. Antiviral Res 81: 103–112. PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e31688